Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Methods Mol Biol ; 2381: 97-112, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34590272

RESUMEN

Genetic perturbation assays have been crucial to the discovery of molecular pathways that drive diverse biological processes. RNA interference (RNAi)-mediated depletion of gene products represents a powerful means of elucidating gene function, as it allows one to systematically probe the phenotypic effects resulting from the functional loss of specific targets. The relative ease of use of RNAi technologies in cultured cells has allowed the design and implementation of genome-wide investigations to systematically reveal gene function. In this chapter, we describe methods for high-throughput RNAi-mediated loss-of-function studies in cultured cells of Drosophila melanogaster. First, we describe the in vitro synthesis of double stranded RNAs (dsRNAs) from a genome-wide Drosophila RNAi library. Next, we outline the procedures used to carry out high-throughput RNAi screens using a cell bathing approach and high-content screening microscopy, illustrating how these experiments can be utilized to study specific cellular contexts, such as cellular stress. Finally, we illustrate some approaches commonly employed to validate the depletion of identified gene candidates.


Asunto(s)
Drosophila melanogaster , Animales , Células Cultivadas , Drosophila melanogaster/genética , Interferencia de ARN , ARN Bicatenario/genética
2.
Genome Res ; 29(11): 1816-1825, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31519740

RESUMEN

RNA sequencing (RNA-seq) is a sensitive and accurate method for quantifying gene expression. Small samples or those whose RNA is degraded, such as formalin-fixed paraffin-embedded (FFPE) tissue, remain challenging to study with nonspecialized RNA-seq protocols. Here, we present a new method, Smart-3SEQ, that accurately quantifies transcript abundance even with small amounts of total RNA and effectively characterizes small samples extracted by laser-capture microdissection (LCM) from FFPE tissue. We also obtain distinct biological profiles from FFPE single cells, which have been impossible to study with previous RNA-seq protocols, and we use these data to identify possible new macrophage phenotypes associated with the tumor microenvironment. We propose Smart-3SEQ as a highly cost-effective method to enable large gene expression profiling experiments unconstrained by sample size and tissue availability. In particular, Smart-3SEQ's compatibility with FFPE tissue unlocks an enormous number of archived clinical samples; combined with LCM it allows unprecedented studies of small cell populations and single cells isolated by their in situ context.


Asunto(s)
Perfilación de la Expresión Génica/métodos , Captura por Microdisección con Láser/métodos , Análisis de Secuencia de ARN/métodos , Análisis de la Célula Individual/métodos , Humanos , Macrófagos/metabolismo , Reproducibilidad de los Resultados , Microambiente Tumoral
3.
Neuron ; 103(5): 802-819.e11, 2019 09 04.
Artículo en Inglés | MEDLINE | ID: mdl-31272829

RESUMEN

Stress granules (SGs) form during cellular stress and are implicated in neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD). To yield insights into the role of SGs in pathophysiology, we performed a high-content screen to identify small molecules that alter SG properties in proliferative cells and human iPSC-derived motor neurons (iPS-MNs). One major class of active molecules contained extended planar aromatic moieties, suggesting a potential to intercalate in nucleic acids. Accordingly, we show that several hit compounds can prevent the RNA-dependent recruitment of the ALS-associated RNA-binding proteins (RBPs) TDP-43, FUS, and HNRNPA2B1 into SGs. We further demonstrate that transient SG formation contributes to persistent accumulation of TDP-43 into cytoplasmic puncta and that our hit compounds can reduce this accumulation in iPS-MNs from ALS patients. We propose that compounds with planar moieties represent a promising starting point to develop small-molecule therapeutics for treating ALS/FTD.


Asunto(s)
Esclerosis Amiotrófica Lateral/metabolismo , Gránulos Citoplasmáticos/efectos de los fármacos , Proteínas de Unión al ADN/efectos de los fármacos , Demencia Frontotemporal/metabolismo , Neuronas Motoras/efectos de los fármacos , Agregación Patológica de Proteínas/metabolismo , Bibliotecas de Moléculas Pequeñas/farmacología , Estrés Fisiológico/efectos de los fármacos , Línea Celular , Gránulos Citoplasmáticos/metabolismo , ADN Helicasas/genética , Proteínas de Unión al ADN/metabolismo , Células HEK293 , Ribonucleoproteína Heterogénea-Nuclear Grupo A-B/metabolismo , Ensayos Analíticos de Alto Rendimiento , Humanos , Células Madre Pluripotentes Inducidas , Proteínas Intrínsecamente Desordenadas , Neuronas Motoras/metabolismo , Células-Madre Neurales/efectos de los fármacos , Células-Madre Neurales/metabolismo , Proteínas de Unión a Poli-ADP-Ribosa/genética , ARN Helicasas/genética , Proteínas con Motivos de Reconocimiento de ARN/genética , Proteína FUS de Unión a ARN/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...